JP2022529036A5 - - Google Patents
Info
- Publication number
- JP2022529036A5 JP2022529036A5 JP2021561772A JP2021561772A JP2022529036A5 JP 2022529036 A5 JP2022529036 A5 JP 2022529036A5 JP 2021561772 A JP2021561772 A JP 2021561772A JP 2021561772 A JP2021561772 A JP 2021561772A JP 2022529036 A5 JP2022529036 A5 JP 2022529036A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- variable domain
- antigen
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023097183A JP7601952B2 (ja) | 2019-04-17 | 2023-06-13 | 二重特異性抗体 |
| JP2024212212A JP7882929B2 (ja) | 2019-04-17 | 2024-12-05 | 二重特異性抗体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19169704.4 | 2019-04-17 | ||
| EP19169704 | 2019-04-17 | ||
| EP19213867.5 | 2019-12-05 | ||
| EP19213867 | 2019-12-05 | ||
| PCT/EP2020/060579 WO2020212415A1 (en) | 2019-04-17 | 2020-04-15 | Bispecific antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023097183A Division JP7601952B2 (ja) | 2019-04-17 | 2023-06-13 | 二重特異性抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529036A JP2022529036A (ja) | 2022-06-16 |
| JP2022529036A5 true JP2022529036A5 (cg-RX-API-DMAC7.html) | 2023-04-25 |
| JP7297928B2 JP7297928B2 (ja) | 2023-06-26 |
Family
ID=70189980
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561772A Active JP7297928B2 (ja) | 2019-04-17 | 2020-04-15 | 二重特異性抗体 |
| JP2023097183A Active JP7601952B2 (ja) | 2019-04-17 | 2023-06-13 | 二重特異性抗体 |
| JP2024212212A Active JP7882929B2 (ja) | 2019-04-17 | 2024-12-05 | 二重特異性抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023097183A Active JP7601952B2 (ja) | 2019-04-17 | 2023-06-13 | 二重特異性抗体 |
| JP2024212212A Active JP7882929B2 (ja) | 2019-04-17 | 2024-12-05 | 二重特異性抗体 |
Country Status (19)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20212262A1 (es) * | 2019-04-17 | 2021-11-29 | Novo Nordisk As | Anticuerpos biespecificos |
| CN116137870B (zh) | 2020-10-12 | 2025-02-18 | 日本制铁株式会社 | 热浸镀锌钢板 |
| JP2025506341A (ja) * | 2022-02-03 | 2025-03-11 | アイジーエム バイオサイエンシズ インコーポレイテッド | 抗cd38結合分子及びその使用 |
| CN118786148A (zh) * | 2022-03-02 | 2024-10-15 | 诺和诺德医疗保健公司 | 每周一次施用fviii模拟双特异性抗体的方法 |
| CN116854821A (zh) * | 2022-08-15 | 2023-10-10 | 海徕科(北京)生物技术有限公司 | IL-15突变体-Fc/IL-15Rα亚基-Fc异源二聚体及其用途 |
| TW202546001A (zh) * | 2024-02-08 | 2025-12-01 | 丹麥商赫邁博私人有限責任公司 | 用於治療凝血病變的方法 |
| CN119285785B (zh) * | 2024-09-26 | 2025-04-18 | 武汉奥科博泰生物科技有限公司 | 一种抗d-二聚体单克隆抗体及其应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6541275B1 (en) | 1988-02-03 | 2003-04-01 | Dade Behring Inc. | Immunoassay for F1.2 prothrombin fragment |
| TW212184B (cg-RX-API-DMAC7.html) | 1990-04-02 | 1993-09-01 | Takeda Pharm Industry Co Ltd | |
| US5506134A (en) | 1990-10-22 | 1996-04-09 | Corvas International, Inc. | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
| JPH05168494A (ja) | 1991-05-17 | 1993-07-02 | Takeda Chem Ind Ltd | ハイブリッド・モノクローナル抗体および抗体含有薬剤 |
| EP0771216B9 (en) | 1994-07-11 | 2003-01-02 | The Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of tumoral vasculature |
| EP0979281B1 (en) | 1997-05-02 | 2005-07-20 | Genentech, Inc. | A method for making multispecific antibodies having heteromultimeric and common components |
| DE19802139C1 (de) | 1998-01-22 | 1999-09-23 | Centeon Pharma Gmbh | Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung |
| US20040180409A1 (en) | 2003-03-16 | 2004-09-16 | Mcvicar Daniel | TLT-1, a novel platelet-associated receptor and uses therefor |
| AU2003271174A1 (en) | 2003-10-10 | 2005-04-27 | Chugai Seiyaku Kabushiki Kaisha | Double specific antibodies substituting for functional protein |
| DE10354403A1 (de) | 2003-11-20 | 2005-06-23 | Dade Behring Marburg Gmbh | Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung |
| US7393833B2 (en) | 2005-03-09 | 2008-07-01 | The Board Of Regents Of The University Of Oklahoma | Chimeric proteins with phosphatidylserine binding domains |
| ES2353084T3 (es) | 2006-04-07 | 2011-02-25 | Novo Nordisk Health Care Ag | Complejo covalente de factor vii y factor tisular. |
| US7553936B2 (en) | 2006-12-04 | 2009-06-30 | The United States of America as represented by Secretary Department of Health and Human Services | Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions |
| US20110077202A1 (en) | 2008-05-16 | 2011-03-31 | Bayer Healthcare Llc | Targeted Coagulation Factors and Method of Using the Same |
| UA109633C2 (uk) | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
| CN102361884A (zh) * | 2009-04-07 | 2012-02-22 | 罗氏格黎卡特股份公司 | 双特异性抗-ErbB-2/抗-c-Met抗体 |
| WO2010132370A2 (en) | 2009-05-11 | 2010-11-18 | Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Soluble tlt-1 for the treatment and diagnosis of sepsis |
| WO2011023785A1 (en) | 2009-08-27 | 2011-03-03 | Novo Nordisk A/S | Targeting tissue factor to activated platelets |
| CN103153327B (zh) | 2010-04-08 | 2016-01-20 | 国家健康与医学研究院 | 衍生自trem样转录1(tlt-1)的抑制肽和其用途 |
| PT2591006T (pt) | 2010-07-09 | 2019-07-29 | Bioverativ Therapeutics Inc | Moléculas de cadeia simples processáveis e polipéptidos preparados utilizando as mesmas |
| CN104788557A (zh) | 2010-09-15 | 2015-07-22 | 诺沃—诺迪斯克有限公司 | 具有减少的细胞摄取的因子viii变体 |
| CN105859889B (zh) | 2010-11-17 | 2020-01-07 | 中外制药株式会社 | 具有代替凝血因子viii的功能的功能的多特异性抗原结合分子 |
| AU2012222366A1 (en) * | 2011-03-02 | 2013-08-01 | Novo Nordisk A/S | Coagulation factor-targeting to TLT-1 on activated platelets |
| CA3034105A1 (en) | 2016-09-23 | 2018-03-29 | Csl Limited | Coagulation factor binding proteins and uses thereof |
| AU2018216008A1 (en) * | 2017-02-01 | 2019-08-01 | Novo Nordisk A/S | Procoagulant antibodies |
| PE20212262A1 (es) * | 2019-04-17 | 2021-11-29 | Novo Nordisk As | Anticuerpos biespecificos |
-
2020
- 2020-04-15 PE PE2021001714A patent/PE20212262A1/es unknown
- 2020-04-15 EP EP20717228.9A patent/EP3956359A1/en active Pending
- 2020-04-15 BR BR112021019959A patent/BR112021019959A2/pt unknown
- 2020-04-15 JP JP2021561772A patent/JP7297928B2/ja active Active
- 2020-04-15 WO PCT/EP2020/060579 patent/WO2020212415A1/en not_active Ceased
- 2020-04-15 CA CA3135632A patent/CA3135632A1/en active Pending
- 2020-04-15 MX MX2021012365A patent/MX2021012365A/es unknown
- 2020-04-15 AU AU2020259982A patent/AU2020259982B2/en active Active
- 2020-04-15 PH PH1/2021/552586A patent/PH12021552586A1/en unknown
- 2020-04-15 KR KR1020217035470A patent/KR102652906B1/ko active Active
- 2020-04-15 CN CN202080028632.2A patent/CN113692415B/zh active Active
- 2020-04-15 MA MA055705A patent/MA55705A/fr unknown
- 2020-04-15 MY MYPI2021005843A patent/MY206180A/en unknown
- 2020-04-15 KR KR1020247010125A patent/KR20240046282A/ko active Pending
-
2021
- 2021-09-29 IL IL286757A patent/IL286757A/en unknown
- 2021-10-01 ZA ZA2021/07426A patent/ZA202107426B/en unknown
- 2021-10-14 US US17/501,548 patent/US11325983B2/en active Active
- 2021-10-14 SA SA521430592A patent/SA521430592B1/ar unknown
- 2021-10-15 CL CL2021002710A patent/CL2021002710A1/es unknown
- 2021-10-21 CO CONC2021/0014072A patent/CO2021014072A2/es unknown
-
2022
- 2022-03-21 US US17/699,460 patent/US12122847B2/en active Active
-
2023
- 2023-06-13 JP JP2023097183A patent/JP7601952B2/ja active Active
-
2024
- 2024-09-06 US US18/827,611 patent/US20250002607A1/en active Pending
- 2024-12-05 JP JP2024212212A patent/JP7882929B2/ja active Active